Strategic collaborations, home care drug delivery devices, and expanding applications of drug delivery into niche therapeutic areas represent vast opportunities for major shareholders of this market. With the growing number of elderly persons, the demand for home care drug delivery devices is also on the rise.
Striking right partnership deal and enhancing the bioavailability of drugs are key burning issues in this market. In spite of a large number of strategic collaborations taking place every year, pharmaceutical and biotechnology companies are facing problems in finding a the right drug delivery partner. Considering this need, a number of national and international conferences are organized by various associations and organizations to facilitate drug delivery partnerships.
North America is the largest market for drug delivery, followed by Europe and Asia. North America and Europe has a well-established pharmaceutical industry, which has stimulated the growth of the drug delivery market in these regions. The Asian market is expected to witness a double digit growth over the next five years, owing to the flourishing pharmaceutical industry, development of healthcare infrastructure, and rising disposable income.
Key players in the drug delivery technologies market are 3M Company (U.S.), Alkermes (Ireland), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.), SkyePharma PLC (U.K.), and Ypsomed Holding AG (Switzerland).
Browse related reports
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebuli
Copyright©2012 Vocus, Inc.
All rights reserved